11th Central European Congress of Rheumatology,...

11th Central European Congress of Rheumatology, 8th – 10th December 2016, Prague, Czech Republic

2

15:45 - 17:15 General Session 2: Cardiovascular manifestations of rheumatic diseases Chair: Anic B, Morović-Vergles J Hall Zenit

15:45 - 16:05 0:20 O 9. Impact of treatment with biological disease modifying antiinflammatory drugs on atherosclerosis in rheumatoid arthritis patients.

Iztok Holc, Artur Paho (University Clinical Center Maribor, Maribor, Slovenia)

16:05 - 16:25 0:20 O 10. Association between anti-cyclic citrullinated peptide antibodies and myocardial involvement in patients with active rheumatoid arthritis.

Danijela Marasović-Krstulović, Duška Martinović-Kaliterna (University Hospital Center Split, Split, Croatia)

16:25 - 16:45 0:20 O 11. Differences in the prevalence of arterial hypertension and metabolic syndrome in patients with rheumatoid arthritis and patients with osteoarthritis: The results of our study.

Lea Šalamon, Jadranka Morović-Vergles (University Hospital Dubrava, Zagreb, Croatia)

16:45 - 16:55 0:10 O 12. Ambulatory arterial stiffness index and carotid intima-media thickness in hypertensive rheumatoid patients: experience in our center.

Mitrovic Josko (Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Dubrava University Hospital, University of Zagreb School of Medicine, Zagreb, Croatia)

16:55 - 17:05 0:10 O 13. Comparison of clinical characteristics of diabetes mellitus patients with and without scleredema buschke skin disorder..

Varjú Cecilia (University of Pécs, Pécs, Hungary)

17:05 - 17:15 0:10 O 14. Arterial stiffness in systemic lupus erythematosus and lupus nefritis patients.

Schubertová Markéta (Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc, Olomouc, Czech Republic)

17:15 - 17:45 0:30 Break -foyer Lobby

17:45 - 18:45 Satellite Symposium 1 - Immunology Update 2016 (MSD)

Chair: Smolen J, Vencovský J Hall Zenit

17:45 - 18:00 0:15 The difficult choice - Comparing the efficacy of different biological DMARDs, Smolen J, Vienna, Austria

18:00 - 18:15 0:15 Use of antirheumatic drugs during pregnancy and lactation. Vencovsky J, Prague, Czech Republic

18:15 - 18:30 0:15 Uveitis in rheumatic disorders and its therapeutic possibilities. Heissigerova J, Prague, Czech Republic

18:30 - 18:45 0:15 Impact of AS on work disability and influence of anti TNF therapy. Pavelka K, Prague, Czech Republic

17:45 - 18:45 Satellite Symposium 2 - Right treatment for the right patient - making successful therapeutic

decisions based on different patient profiles (UCB) Chair: Kucharz EJ, Szekanecz Z. Hall Nadir

17:45 - 18:00 0:15 News in the diagnosis and treatment of axSpA and nr-axSpA patients. Pavelka K, Prague, Czech Republic

18:00 - 18:15 0:15 Role of MRI in early diagnostic of nr-AxSpA patients. Žlnay M, Piešťany, Slovakia

18:15 - 18:30 0:15 Early diagnosis and guideliness in rheumatoid arthritis. Kucharz EJ, Katowicz, Poland

18:30 - 18:45 0:15 Differences between anti-TNFs - what do the H2H studies tell us? Psenak O, Salzburg, Austria

19:15 - 22:15 3:00 Networking

Congress foyer, Tycho, Kepler


3

Friday, 9th December 2016

8:30 - 10:00 General Session 3: Environmental factors Chair: Szekanecz Z, Czirjak L Hall Zenit

8:30 - 8:42 0:12 O 15. Influence of environmental factors on comorbidities of generalized osteoarthritis.

Eszter Kővári, Péter V. Bálint (National Institute of Rheumatology and Physiotherapy, Budapest, Hungary)

8:42 - 8:54 0:12 O 16. Chemicals and scleroderma.

Laszlo Czirjak (University of Pécs, Department of Rheumatology and Immunology, Pécs, Hungary)

8:54 - 9:06 0:12 O 17. Immune mediated necrotising myopathy associated with statins.

Jiri Vencovsky (Institute of Rheumatology, Prague, Czech Republic)

9:06 - 9:18 0:12 O 18. Diet in gout.

Marton Pálinkás, Gyula Poór (National Institute of Rheumatology and Physiotherapy, Budapest, Hungary)

9:18 - 9:30 0:12 O 19. The salty taste of rheumatoid artrhritis.

Zoltán Szekanecz (University of Debrecen, Hungary)

9:30 - 9:40 0:10 O 20. Exosomes regulate the human osteoclastogenesis. György Nagy (Semmelweis University, Department of Rheumatology, Hungary)

9:40 - 9:50 0:10 O 21. Periodontal status in rheumatoid arthritis and its association with smoking. Laszlo Kovacs et al (University of Szeged, Faculty of Medicine, Department of Rheumatology and

Immunology, Hungary)

9:50 - 10:00 0:10 O 22. Analysis of ABCG2, SLC17A3, SLC22A11and SLC17A1 genes in patients with primary hyperuricemia and gout.

Petrů Lenka (Institute of Rheumatology, Prague, Czech Republic)

10:00 - 10:30 0:30 Break - foyer Lobby

10:30 - 11:30 Satellite Symposium 3 - Decoding the complex interplay in PsA (Celgene)

Chair: Štolfa J, Thaci D Hall Zenit

10:30 - 10:50 0:20 Etiopathogenesis of PsA. Thaci D, Lübeck, Germany

10:50 - 11:10 0:20 Apremilast- a new oral therapy in PsA. Pavelka K, Prague, Czech Republic

11:10 - 11:30 0:20 Apremilast in European and GRAPPA Recommendations. Štolfa J, Šedová L, Prague, Czech Republic

10:30 - 11:30 Satellite Symposium 4 - Treat to target in SpA. (Novartis)

Chair: Smolen J, Vencovský J Hall Nadir

10:30 - 10:45 0:15 T2T in SpA. Smolen J, Vienna, Austria

10:45 - 11:00 0:15 Role of IL-17 in pathophysiology of SpA. Vencovský J, Prague, Czech Republic

11:00 - 11:15 0:15 IL-17 inhibitors (Cos) in the context of the new EULAR PsA guidelines. Praprotnik S, Slovenia

11:15 - 11:30 0:15 IL-17 inhibitors (Cos) in the context of the new EULAR AS guidelines. Mann H, Prague, Czech Republic

11:30 - 11:35 0:05 Technical Break


4

11:35 - 13:05 General Session 4: Psoriatic arthritis. Vasculitis

Chair: Rovenský J, Tesař V Hall Zenit

11:35 - 11:55 0:20 O 23. Disease Activity Assessment in Psoriatic Arthritis - Definition of Remission and other Outcomes.

Josef Smolen (Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Austria)

11:55 - 12:15 0:20 O 24. Giant cell arteritis, polymyalgia rheumatica and ocular involvement.

Jozef Rovenský, Igor Kozák (National Institute of Rheumatic Diseases, Pieštany, Slovakia)

12:15 - 12:35 0:20 O 25. Treatment of ANCA-associated renal vasculitis – beyond KDIGO guidelines.

Vladimír Tesař (Department of Nephrology, First Faculty of Medicine and General University Hospital, Prague, Czech Republic )

12:35 - 12:45 0:10 O 26. ANCA associated vasculitides – clinical and therapeutic association. Jozef Lukáč (Institute of physiotherapy, balneology and medical rehabilitation and National Institute

of Rheumatic Diseases, Piešťany,Slovakia)

12:45 - 12:55 0:10 O 27. Diffuse alveolar hemorrhage: acute, life-threatening vasculitis syndrome.

Bradna Petr (2nd Department of Internal Medicine,3rd Department of internal Medicine, Dept. of Immunology, Charles University Faculty of Med, University hospital, Hradec Kralove, Czech Republic)

12:55 - 13:05 0:10 O 28. Improved clinical outcomes and workability in spondyloarthritides during real-life administration of adalimumab in central and eastern Europe.

Sándor Szántó (Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)

13:05 - 14:05 1:00 Boxed lunch and poster presentations foyer Lobby, Quadrant

14:05 - 15:35 General Session 5: Malignancy and rheumatic diseases. Epidemiology

Chair: Kucharz E, Wiland P. Hall Zenit

14:05 - 14:25 0:20 O 29. Rhemuatic diseases and malignancy: from bench to bedside.

Eugen Kucharz (Department of Internal Medicine and Rheumatology, Medical University of Silesia, Katowice, Poland)

14:25 - 14:45 0:20 O 30. Paraneoplastic syndromes in rheumatology.

Przemyslaw Kotyla (Department of Internal Medicine and Rheumatology, Medical University of Silesia, Katowice, Poland)

14:45 - 15:05 0:20 O 31. Prevalence and clinical characteristics of rheumatoid arthritis in Poland. Bogdan Batko (Department of Rheumathology, J. Dietl Specialist Hospital, Krakow, Poland) presentig

author - Piotr Wiland

15:05 - 15:15 0:10 O 32. The efficacy of stopping biologicals in patients with SpA. Tłustochowicz Małgorzata (Departament of Internal Diseases and Rheumatology, Military Institute

of Medicine, Warszaw, Poland)

15:15 - 15:25 0:10 O 33. Neoplasma in rheumatoid arthritis patients - our experience

Gudelj Gračanin Ana (Division of Clinical Immunology, Allergology and Rheumatology, Department of Internal Medicine, Croatia)

15:25 - 15:35 0:10 O 34. Accumulation of S100A11 protein in rheumatoid arthritis and its correlation with disease activity and inflammation.

Andrés Cerezo Lucie (Institute of Rheumatology, Prague, Czech Republic)

15:35 - 16:05 0:30 Break -foyer Lobby


5

16:05 - 17:05 Satellite Symposium 5 - A different journey is possible for patients with spondyloarthritis

(AbbVie)

Chair: Bálint P, Šenolt L Hall Zenit

16:05 - 16:20 0:15 A different journey is possible for patients with spondyloarthritis. Balint P, Budapest, Hungary

16:20 - 16:35 0:15 Role of Imaging in progression evaluation in patients with axial spondyloarthritis. Grobelná K, Prague, Czech Republic

16:35 - 16:50 0:15 Long-term safety and efficacy of adalimumab for the treatment of ankylosing spondylitis - data from ATTRA registry. Šenolt L, Prague, Czech Republic

16:50 17:05 0:15 Translating PsA guidelines into practice: national guidelines update. Štolfa J, Prague, Czech Republic

16:05 - 17:05 Satellite Symposium 6 (Biogen)

Chair: Vencovský J, Kucharz EJ Hall Nadir

16:05 - 16:25 0:20 Comorbidities in patients with rheumatoid arthritis. Kucharz EJ, Katowicz, Poland

16:25 - 16:45 0:20 Current situation of Biosimilars in Rheumatology. Vencovský J, Prague, Czech Republic

16:45 - 17:05 0:20 EULAR recommendations and their impact on clinical practice in Central Europe. Pavelka K, Prague, Czech Republic

17:05 - 17:10 0:05 Technical Break

17:10 - 18:55 General Session 6: Young rheumatologists from CECR countries

Chair: Šenolt L, Nagy Hall Zenit

17:10 - 17:25 0:15 O 35. Neutrophil CARD9 mediates autoantibody-induced autoimmune diseases by controlling gene expression changes in vivo.

Tamás Németh (Department of Physiology, Semmelweis University School of Medicine, Budapest, Hungary)

17:25 - 17:40 0:15 O 36. Increased interest in polymyalgia rheumatic and giant cell arteritis leads to increased incidence.

Marcin Milchert (Pomeranian Medical University, Klinika Reumatologii, Szcecin, Poland)

17:40 - 17:55 0:15 O 37. Antiprothrombin antibodies in the diagnosis of APS.

Polona Žigon (University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia)

17:55 - 18:10 0:15 O 38. Cytokine responses of T cells, B cells and monocytes in patients with rheumatoid arthritis: effects of IL-35.

Martina Mravcová (Institute of Experimental Endocrinology, Biomedical Research Centre, Slovak Academy of Sciences, Bratislava, Slovakia )

18:10 - 18:25 0:15 O 39. The role of immunosenescene in rheumatic diseases.

Johannes Fessler (Medizinische Universität, Klinische Abteilung für Rheumatologie und Immunologie, Graz, Austria)

18:25 - 18:40 0:15 O 40. Cardiovascular damage in deceased patients with Systhbemic Lupus Erythematosus.

Ivan Padjen (University Hospital Centre Zagreb and University of Zagreb, School of Medicine, Croatia)

18:40 - 18:55 0:15 O 41. IL-35 in the pathogenesis of rheumatic diseases.

Mária Filková (Institute of Rheumatology, Department of Rheumatology of the 1st Faculty of Medicine, Charles University, Czech Republic)

19:00

Departure of busses for networking event from the Hotel Clarion reception

19:45 - 22:45 3:00 Networking event

Villa Richter - Prague Castle


6

Saturday, 10th December 2016

8:30 - 10:00 General Session 7: Antiphospholipid syndrome

Chair: Holc I, Ambrožič A Hall Zenit

8:30 - 8:50 0:20 O 42. Antiphospholipid syndrome: clinical manifestations and treatment.

Aleš Ambrožič (Clinical dept. Of Rheumatology, UMC Ljubljana, Slovenija)

8:50 - 9:10 0:20 O 43. Venous thrombosis and antiphospholipid antibodies.

Katja Perdan Pirkmajer, Aleš Ambrožič (Clinical dept. Of Rheumatology, UMC Ljubljana, Slovenija)

9:10 - 9:30 0:20 O 44. Antiphospholipid antibodies, a possible etiologic factor for cerebrovascular events in younger adult patients.

Nataša Gašperšič (Clinical dept. Of Rheumatology, UMC Ljubljana, Slovenija)

9:30 - 9:45 0:15 O 45. Antiphospholipid antibodies in association to adverse pregnancy outcome.

Polona Žigon (Clinical dept. Of Rheumatology, UMC Ljubljana, Slovenija)

9:45 - 10:00 0:15 O 46. Pregnancy in Antiphospholipid syndrome.

Vesna Kovačič Grobelšek, Iztok Holc (Dept. Of Rheumatology, Division of Internal Medicine, UMC Maribor, Slovenija)

10:00 - 11:00 1:00 Break and poster session foyer Lobby, Quadrant

11:00 - 12:20 General Session 8: Easy and Early Access Rheumatology Chair: Machold K, Nell V Hall Zenit

11:00 - 11:20 0:20 O 47. Providing timely access to Rheumatology Services: review of the International Approaches.

Valerie Nell (Klinikum Peterhof Baden, Austria)

11:20 - 11:40 0:20 O 48. The Austrian Central University Hospital Approach.

Klaus Machold (Medical University of Vienna, Austria)

11:40 - 12:00 0:20 O 49. The Austrian Office Based Cooperative Approach.

Rudolf Puchner (Rheumatology Practice Wels, Austria)

12:00 - 12:10 0:10 O 50. Patients’ dogma, number of swollen joints and physicians’ and patients’ age predict non-adherence to medicines and non-pharmacological interventions in rheumatoid arthritis - a mixed methods study

Ritschl Valentin (Institute of Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Austria)

12:10 - 12:20 0:10 O 51. Effectiveness of a workplace-centered initiative to consuel individuals with musculosceletal complaints (WORIMUCO): A prospective pilot cohort study.

Leiss Harald (MUV, Department of Rheumatology, Austria)

12:20 - 12:35 0:15 Summary and close


7

POSTER SESSIONS: Friday, December 9, from 13:00 - 14:00 hrs - Odd numbers Saturday, December 10, from 10:00 - 11:00 hrs - Even numbers

P1. BACK PAIN: AN UNCOMMON PRESENTATION OF GREAT VESSEL VASCULITIS.

Águeda A, Centro Hospitalar Baixo Vouga E.P.E., Aveiro, Portugal P2. RITUXIMAB CAN INDUCE REMISSION IN A PATIENT WITH ANKYLOSING SPONDYLITIS WHO

FAILED ANTI- TNF-α AGENT. Almetri Talal, Umm Al-Qura University, Mecca, Saudi Arabia

P3. SUCCESSFUL RITUXIMAB TREATMENT OF MULTIPLE CARDIAC INVOLVEMENT IN

GRANULOMATOSIS WITH POLYANGIITIS. Belobradkova Martina, Division Rheumatology, 2nd Department of Internal Medicine – Gastroenterology, Charles University, Hradec Kralove, Czech Republic

P4. SUSAC SYNDROME – A DIAGNOSTIC AND THERAPEUTIC DILEMMA.

Bogna Grygiel-Górniak, Department of Rheumatology and Internal Medicine, Poznan University of Medical Sciences, Poland

P5. DIFFERENCES IN THE INCIDENCE OF SELECTED CLINICAL AND IMMUNOLOGICAL SYMPTOMS

MANIFESTATIONS USED IN THE SLICC CLASSIFICATION SYSTEM IN GROUPS OF LUPUS PATIENTS “WITH” OR “WITHOUT” THE PRESENCE OF ANTI-RO / SSA-60 ANTIBODIES. Dryglewska Magdalena, Department of Rheumatology and Connective Tissue Diseases, Medical University of Lublin, Poland

P6. EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND

INAPPROPRIATE RESPONSE TO CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: 24-WEEK PHASE 3 RA-BUILD STUDY SUMMARY RESULTS. Presented by: Fialova A (non-author presenter) Eli Lilly CR s.r.o., Praha, Czech Republic

P7. PREMATURE SENESCENCE OF NAÏVE T-CELLS IN SJÖGREN’S SYNDROME AND SYSTEMIC

LUPUS ERYTHEMATOSUS. Fasching Patrizia, Medical University of Graz, Austria

P8. A RANDOMIZED, DOUBLE-BLIND, ACTIVE- AND PLACEBO-CONTROLLED PHASE 3 STUDY OF

EFFICACY AND SAFETY OF IXEKIZUMAB, ADALIMUMAB, AND PLACEBO THERAPY IN PATIENTS NAÏVE TO BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS WITH ACTIVE PSORIATIC ARTHRITIS. Presented by: Irtó I (non-author presenter), Lilly Hungária, Budapest, Hungary

P9. BARICITINIB, METHOTREXATE, OR BARICITINIB PLUS METHOTREXATE IN PATIENTS WITH

EARLY RHEUMATOID ARTHRITIS WHO HAD RECEIVED LIMITED OR NO TREATMENT WITH DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: PHASE 3 TRIAL RESULTS. Presented by: Fialova A (non-author presenter) Eli Lilly CR s.r.o., Praha, Czech Republic

P10. COMPARISON OF THE EFFECT OF ANTI-TNF THERAPY ON MEASURES OF PHYSICAL

FUNCTION AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS – RESULTS FROM THE CZECH BIOLOGIC REGISTRY ATTRA. Forejtova Sarka, Institute of Rheumatology and First Faculty of Medicine , Charles University in Prague,

P11. INCOMPLETE ATYPICAL FEMORAL FRACTURE COMPLICATING LONG-TERM USE OF

BISPHOSPHONATES - CASE REPORT.


8

Franeková Lenka, Internal Clinic - Outpatient Department of Rheumatology and Osteology, Military University Hospital, Prague, Czech Republic

P12. PANNICULITIS IN AN OPIOID-ADDICTED PATIENT.

Fryc Justyna, Medical University of Bialystok, Poland P13. PATIENTS WITH AXIAL SPONDYLOARTHRITIS: BASELINE CLINICAL CHARACTERISTIC AND

SUBSETS DIFFERENCES IN SINGLE CENTRE COHORT. Grobelná Kristýna, Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic

P14. ANNUAL CHANGES OF SERUM SURFACTANT PROTEIN D IN PATIENTS WITH SYSTEMIC

SCLEROSIS. Grosicka Anida, Medical University of Silesia, Department of Internal Medicine and Rheumatology, Katowice, Poland

P15. POLYSEROSITIS AS A PARANEOPLASTIC SYNDROME IN THYROID GLAND CANCER.

Henyšova Veronika, Institute of Rheumatology and Clinic of Rheumatology 1st Faculty of Medicine of Charles University, Prague, Czech Republic

P16. CHRONIC DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS IS ASSOCIATED WITH INCREASED

SERUM LEVELS OF IL6, IL8 AND CCL2/MCP1. Horák Pavel, 3rd Department of Internal Medicine, University Hospital of Olomouc, Faculty of Medicine and Dentistry, Palacký University of Olomouc, Olomouc, Czech Republic

P17. B CELL ACTIVATING FACTOR (BAFF) IN SERUM AND SYSTEMIC LUPUS ERYTHEMATOSUS

DISEASE ACTIVITY USING SLEDAI-2K SCORING SYSTEM (EAST BOHEMIAN REGIONAL STUDY). Hrncir Zbynek, 2nd Department of Internal Medicine, Charles University Hospital, Hradec Králové, Czech Republic

P18. HIGH BASELINE EXPRESSION OF CIRCULATING MICRORNA-342-3P PREDICTS POOR

RESPONSE TO THERAPY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS . Hruskova Veronika, Institute of Rheumatology and Dpt. of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

P19. THE EFFECT OF BIOLOGICAL TREATMENT ON SERUM TENASCIN-C IN PATIENTS WITH LONG-LASTING RHEUMATOID ARTHRITIS . Hulejová Hana, Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

P20. SERUM CALPROTECTIN DISTINGUISHES SUBCLINICAL DISEASE ACTIVITY FROM

ULTRASOUND-DEFINED REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION. Hurnakova Jana, Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic

P21. THE CLINICAL IMPROVEMENT AND BIOMARKER CHANGES AFTER INTENSIVE EXERCISE

PROGRAMME FOR NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND FOR ANKYLOSING SPONDYLITIS. . Hušáková Markéta, Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic

P22. VITAMIN D IN RHEUMATOID ARTHRITIS: ITS RELATIONSHIP WITH AUTOANTIBODIES AND LABORATORY DISEASE ACTIVITY MARKERS. Iwaszkiewicz Cezary, Department of Rheumatology and Osteoporosis, Jozef Strus Municipal Hospital in Poznan, Poznań, Poland


9

P23. PREGNANCY OUTCOMES IN ADULT JUVENILE IDIOPATHIC ARTHRITIS PATIENTS TREATED

WITH BIOLOGIC AGENTS. Jarosova Katerina, Institute of Rheumatology, Prague, Czech Republic

P24. SERUM OSTEOPONTIN LEVEL IN PATIENTS WITH RHEUMATOID ARTHRITIS .

Kopec-Medrek M., Department of Internal Medicine and Rheumatology, Poland P25. POLYMYOSITIS AS A MASK OF AMYOTROPHIC LATERAL SCLEROSIS – DIAGNOSTIC

DIFFICULTIES. Koszarny Arkadiusz, Medical University of Lublin, Poland

P26. SATISFACTION AND DISSATISFACTION OF PATIENTS WITH RHEUMATIC DISEASES

RECEIVING BIOLOGICS. Kotulska Anna, Medical University of Silesia, Katowice, Poland

P27. THE COMPARISON OF THE EFFICACY AND SAFETY OF PHENYRAMIDOL AND

PHENYRAMIDOL + DICLOFENAC IN ACUTE SPINAL PAINFUL MUSCLE SPASM- AN OPEN STUDY. Koyuncu Halil, IU,Cerrahpasa Medical Faculty,Physical Medicine and Rehabilitation Department,Istanbul, Turkey

P28. IMPAIRED MOUTH STATE IN PATIENTS WITH SYSTEMIC SCLEROSIS CORRELATED WITH SKIN

INVOLVEMENT. Kramza Justyna, Department of Internal Medicine and Rheumatology, Medical University of Silesia, Katowice, Poland

P29. ON THE 150TH BIRTH ANNIVERSARY OF DR. EDMUND FAUSTYN BIERNACKI AND HIS

FORGOTTEN CONTRIBUTION TO THE DISCOVERY OF ERYTHROCYTE SEDIMENTATION RATE. Kucharz Eugene J, Department of Internal Medicine and Rheumatology, Medical University of Silesia, Katowice, Poland

P30. THE INCIDENCE OF HYPERSENSITIVITY TO NSAIDS IN THE GROUP OF PATIENTS WITH

MUSCULOSKELETAL DISORDERS. Lewandowska-Polak Anna, Medical University of Lodz, Poland

P31. TUMOR-INDUCED HYPOPHOSPHATEMIC OSTEOMALACIA: A CASE REPORT.

Lokočová Eva, 3rd Department of Internal medicine-NRE, University Hospital and Faculty of Medicine

Palacký University, Olomouc, Czech Republic P32. OCCURRENCE MALIGNANCIES IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH

A TNF-BLOCKING AGENTS – OBSERVATION IN SLOVAK COHORT. Lukáčová Olga, Národný ústav reumatických chorôb, Piešťany, Slovakia

P33. CLINICAL PRESENTATION OF PATIENTS WITH THE PRESENCE OF ANTISYNTHETASE

AUTOANTIBODIES. Masiak Anna, Clinic of Internal Medicine, Connective Tissue Diseases and Geriatrics, Medical University of Gdansk, Poland

P34. APPLICATION OF TREAT TO TARGET PRINCIPLES IN PATIENTS WITH EARLY RHEUMATOID

ARTHRITIS IN ROUTINE CLINICAL PRACTICE IN CENTRAL - EASTERN EUROPE. Codreanu C, "Dr. Ion Stoia" Center for Rheumatic Diseases, University of Medicine and Pharmacy "Carol Davila" Bucharest, Romania

P35. ANALYSIS OF NON-TYPHOID SALMONELLA INFECTIONS IN THE CZECH POPULATION OF SLE

PATIENTS. A RETROSPECTIVE, 20 YEARS STUDY.


10

Olejárová Marta, Institute of Rheumatology, Prague and Clinic of Rheumatology, Ist Medical Faculty, Charles University, Prague, Czech Republic

P36. ASSOCIATION OF HLA-DRB1 ALLELES WITH MIXED CONNECTIVE TISSUE DISEASE (MCTD).

Paradowska-Gorycka Agnieszka, Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

P37. GENETIC VARIANTS IN IL-12B AND IL-27 IN THE PATIENTS WITH SYSTEMIC LUPUS

ERYTHEMATOSUS. Paradowska-Gorycka Agnieszka, Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

P38. IL-12B GENE POLYMORPHISMS AND IL-12 P70 SERUM LEVEL AMONG POLISH PATIENTS WITH

RHEUMATOID ARTHRITIS. Paradowska-Gorycka Agnieszka, Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

P39. ASSOCIATION BETWEEN THE STAT3 POLYMORPHISMS, VEGF SERUM LEVEL AND

RHEUMATOID ARTHRITIS IN POLISH POPULATION. Paradowska-Gorycka Agnieszka, Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

P40. FLT1 GENETIC VARIATION AFFECTS THE CLINICAL RHEUMATOID ARTHRITIS PHENOTYPE.


P41. DETECTION OF POLYMORPHISMS IN TPMT GENE BEFORE STARTING AZATHIOPRINE

THERAPY. Pavelcova Katerina, Institute of Rheumatology, Prague, Czech Republic

P42. MiR-451 DIFFERENTIATES PATIENTS WITH CLINICALLY SUSPECT ARTHRALGIA FROM

HEALTHY CONTROLS. Prajzlerová Klára, Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

P43. INTERMETATARSAL BURSITIS AS A MANIFESTATION OF RHEUMATOID ARTHRITIS – CASE

PRESENTATION. Reihl Mirna, General Hospital Vukovar, Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital Centre Zagreb , Croatia

P44. PAEDIATRIC RHEUMATOLOGIST AND ORPHAN DISEASE – A STORY WITHOUT HAPPY

ENDING. Roszkiewicz Justyna, Department of Paediatric Rheumatology, Medical University of Lodz, Poland

P45. REFERRAL OF EARLY ARTHRITIS PATIENTS TO A RHEUMATOLOGY CLINIC - A MODEL

DEVELOPED IN A CROATIAN TERTIARY CENTRE. Rukavina Krešimir, University Hospital Centre Zagreb, Croatia

P46. RELATIONSHIP BETWEEN RHEUMATOID ARTHRITIS DISEASE ACTIVITY ASSESSED WITH THE

US7 SCORE AND QUALITY OF LIFE MEASURED WITH QUESTIONNAIRES (HAQ, EQ-5D, WPAI). Skácelová Martina, 3rd Department of Internal Medicine, University Hospital of Olomouc, Faculty of Medicine and Dentistry, Palacký University of Olomouc

P47. THE RELATIONSHIP BETWEEN INFLAMMATORY PARAMETERS AND CLINICAL MANIFESTATIONS OF EARLY SPONDYLOARTHRITIS.


11

Skoczynska Marta, Department and Clinic of Rheumatology and Internal Medicine, Wroclaw Medical University, Poland

P48. INTIMA MEDIA THICKNESS AND ATHEROSCLEROTIC PLAQUES AS A MARKERS OF

SUBCLINICAL ATHEROSCLEROSIS AND CARDIOVASCULAR MANIFESTATION IN SLE PATIENTS. Smržová Andrea, 3rd Department Of Internal Medicine – Nephrology, Rheumatology And Endocrinology, Faculty Hospital and University Palacky Olomouc, Czech Republic

P49. THE INFLUENCE OF CAFFEINE CONSUMPTION ON THE THERAPEUTIC EFFECTS OF

METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN PATIENTS WITH DIFFERENT ADORA2A GENOTYPES. Soukup Tomáš, Charles University, Faculty of Medicine and University Hospital in Hradec Kralove, 2nd Department of Internal Medicine-Gastroenterology, Division of Rheumatology, Czech Republic

P50. DECREASED BODY FAT, LEAN BODY MASS AND BONE MINERAL DENSITY IN SCLERODERMA

PATIENTS ARE ASSOCIATED WITH DISEASE ACTIVITY AND PHYSICAL ACTIVITY. Śpiritović Maja, Institute of Rheumatology, Dept. of Rheumatology, 1st Faculty of Medicine and Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic

P51. INCREASED BODY FAT BUT DECREASED LEAN BODY MASS AND BONE MINERAL DENSITY IN

MYOSITIS PATIENTS ARE ASSOCIATED WITH DISEASE DURATION, INFLAMMATORY STATUS, SKELETAL MUSCLE INVOLVEMENT AND PHYSICAL ACTIVITY. Śpiritović Maja, Institute of Rheumatology, Dept. of Rheumatology, 1st Faculty of Medicine and Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic

P52. PROGRESSION OF PAIN AND ULTRASOUND DETECTED SYNOVITIS IN PATIENTS WITH

EROSIVE HAND OSTEOARTHRITIS OVER ONE YEAR. Šléglová Olga, Institute of Rheumatology, Prague, Czech Republic

P53. ELEVATED HEAT SHOCK PROTEIN 90 IN MUSCLE TISSUE AND PLASMA IN IDIOPATHIC

INFLAMMATORY MYOPATHIES IS ASSOCIATED WITH SKELETAL MUSCLE INVOLVEMENT AND DISEASE ACTIVITY. Štorkánová Hana, Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

P54. S100A PROTEINS EFFECTIVELY DISCRIMINATE SLE PATIENTS FROM HEALTHY CONTROLS,

BUT THEIR LEVELS DO NOT ASSOCIATE WITH MEASURES OF DISEASE ACTIVITY. Šumová Barbora, Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

P55. BARICITINIB VERSUS PLACEBO OR ADALIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID

ARTHRITIS AND AN INADEQUATE RESPONSE TO BACKGROUND METHOTREXATE THERAPY: RESULTS OF A PHASE 3 STUDY. Presented by: Irtó I (non-author presenter), Lilly Hungária, Budapest, Hungary

P56. PREGNANCY OUTCOMES IN A COHORT OF WOMEN WITH ANTIPHOSPHOLIPID SYNDROME.

20- YEARS LONG- TERM OBSERVATION. Tegzová Dana, Institute of Rheumatology, Prague, Czech Republic

P57. IMPACT OF HIF-1Α GENE POLYMORPHISMS AND ITS PROTEIN LEVEL ON RA ACTIVITY.


P58. THE LEVELS OF SOLUBLE CD163 IN PATIENTS WITH ANKYLOSING SPONDYLITIS..


12

Tošovský Marián, 2nd Department of Internal Medicine, Charles University Hospital, Hradec Králové, Czech Republic

P59. ATHEROSCLEROSIS, HYPERTENSION, ADULT TYPE II DIABETES MELLITUS AND ISOLATED

AMYLOIDOSIS LOCALIZED TO THE ISLETS OF LANGERHANS – A POSTMORTEM CLINICOPATHOLOGIC STATISTICAL STUDY OF 161 RHEUMATOID ARTHRITIS PATIENTS. Apáthy Ágnes, Department of Rheumatology – St. Margaret Clinic Budapest, Hungary

P60. EVALUATION OF THE PAIN LEVEL IN PATIENTS WITH GOUT. Vatseba Mariana, Ivano-Frankivsk state Medical Universuty, Ivano-Franlivsk, Ukraine

P61. EVALUATION OF THE LEFT VENTRICULAR FUNCTION IN PATIENTS WITH SYSTEMIC

SCLEROSIS AND MIXED CONNECTIVE TISSUE DISEASE. Vymětal Jiří, 3rd Department of Internal Medicine - nephrology, rheumatology and endocrinology, University Hospital in Olomouc, Czech Republic

P62. EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID

ARTHRITIS AND INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: 24-WEEK PHASE 3 RA-BEACON STUDY RESULTS. Presented by: Irtó I (non-author presenter), Lilly Hungária, Budapest, Hungary

P63. THE RELATIONSHIP BETWEEN SYNOVITIS QUANTIFIED BY AN ULTRASOUND 7-JOINT

INFLAMMATION SCORE AND PHYSICAL DISABILITY IN RHEUMATOID ARTHRITIS – A COHORT STUDY. Závada Jakub, Institute of Rheumatology, Prague, Czech Republic

P64. DIAGNOSTICS OF VASCULITIS OF THE SMALL INTESTINE IN GRANULOMATOSIS WITH POLYANGIITIS Kopecká Iveta, Department of Pathology and Anatomy, Trnava University Hospital, Slovakia

11th Central European Congress of Rheumatology,...

Documents

Transcript of 11th Central European Congress of Rheumatology,...